Yimeng Lu

1.3k total citations · 1 hit paper
15 papers, 976 citations indexed

About

Yimeng Lu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Plant Science. According to data from OpenAlex, Yimeng Lu has authored 15 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 2 papers in Plant Science. Recurrent topics in Yimeng Lu's work include Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Ginseng Biological Effects and Applications (2 papers) and Inhalation and Respiratory Drug Delivery (2 papers). Yimeng Lu is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Ginseng Biological Effects and Applications (2 papers) and Inhalation and Respiratory Drug Delivery (2 papers). Yimeng Lu collaborates with scholars based in United States, China and United Kingdom. Yimeng Lu's co-authors include Edward F. McKone, À. Munck, Alexander Mœller, Julie Lekstrom-Himes, Jennifer L. Taylor‐Cousar, J.S. Elborn, Cornelis K. van der Ent, C Simard, Linda T. Wang and Edward P. Ingenito and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Statistical Association and Annals of Neurology.

In The Last Decade

Yimeng Lu

14 papers receiving 951 citations

Hit Papers

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Hom... 2017 2026 2020 2023 2017 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
    2017 553 citations Jennifer L. Taylor‐Cousar, À. Munck et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yimeng Lu United States 8 843 319 104 66 39 15 976
Kaisheng Yin China 17 308 0.4× 544 1.7× 132 1.3× 14 0.2× 67 1.7× 50 800
Takatsugu Kojima Japan 15 187 0.2× 332 1.0× 199 1.9× 11 0.2× 35 0.9× 37 755
Arunava Ghosh United States 12 261 0.3× 294 0.9× 151 1.5× 11 0.2× 39 1.0× 25 628
Martina Antošová Slovakia 12 146 0.2× 125 0.4× 68 0.7× 12 0.2× 13 0.3× 34 352
Petra Košútová Slovakia 9 209 0.2× 54 0.2× 265 2.5× 105 1.6× 48 1.2× 26 587
Misbahuddin M. Rafeeq Saudi Arabia 11 125 0.1× 52 0.2× 168 1.6× 20 0.3× 32 0.8× 51 491
Zenglin Liao China 11 185 0.2× 87 0.3× 154 1.5× 9 0.1× 45 1.2× 17 460
Sanghun Lee South Korea 14 84 0.1× 83 0.3× 201 1.9× 36 0.5× 61 1.6× 62 583
Nora Esteban-Cruciani United States 11 112 0.1× 63 0.2× 151 1.5× 28 0.4× 82 2.1× 18 598
Martijn L. Manson Sweden 10 113 0.1× 210 0.7× 111 1.1× 4 0.1× 31 0.8× 18 659

Countries citing papers authored by Yimeng Lu

Since Specialization
Citations

This map shows the geographic impact of Yimeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yimeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yimeng Lu more than expected).

Fields of papers citing papers by Yimeng Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yimeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yimeng Lu. The network helps show where Yimeng Lu may publish in the future.

Co-authorship network of co-authors of Yimeng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yimeng Lu. A scholar is included among the top collaborators of Yimeng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yimeng Lu. Yimeng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Asselah, Tarik, Michael A. Chattergoon, Alina Jucov, et al.. (2025). A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D. New England Journal of Medicine. 394(4). 343–353. 1 indexed citations
2.
Liu, Xinzhan, Ling Yang, Yan Wang, Pengfei Yan, & Yimeng Lu. (2023). Effects of Fireworks Burning on Air Quality during the Chinese Spring Festival—Evidence from Zhengzhou, China. Toxics. 12(1). 23–23. 4 indexed citations
3.
Huang, Cheng, Chenghao Chu, Yimeng Lu, Bingming Yi, & Ming‐Hui Chen. (2023). Bayesian Interim Analysis in Basket Trials. 54–71.
4.
Kennedy, Zachary, Yuzhen Wang, Yimeng Lu, et al.. (2022). Imaging Net Retrograde Axonal Transport In Vivo: A Physiological Biomarker. Annals of Neurology. 91(5). 716–729. 10 indexed citations
5.
6.
7.
Wang, Baolin, Yimeng Lu, Rong Wang, et al.. (2020). Transport and metabolic profiling studies of amentoflavone in Caco-2 cells by UHPLC-ESI-MS/MS and UHPLC-ESI-Q-TOF-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 189. 113441–113441. 20 indexed citations
8.
Wang, Baolin, Yimeng Lu, Xiaolong Hu, et al.. (2020). Systematic Strategy for Metabolites of Amentoflavone In Vivo and In Vitro Based on UHPLC-Q-TOF-MS/MS Analysis. Journal of Agricultural and Food Chemistry. 68(50). 14808–14823. 18 indexed citations
9.
Taylor‐Cousar, Jennifer L., À. Munck, Edward F. McKone, et al.. (2017). Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del. New England Journal of Medicine. 377(21). 2013–2023. 553 indexed citations breakdown →
10.
Kerwin, Edward, Jacques Hébert, Nicola Gallagher, et al.. (2012). Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study. European Respiratory Journal. 40(5). 1106–1114. 180 indexed citations
11.
Kerwin, Edward, Andrew Pedinoff, Thomas B. Casale, et al.. (2012). NVA237 Once Daily Reduces COPD Exacerbations With Similar Rates To Tiotropium: The GLOW2 Trial. A2255–A2255. 2 indexed citations
12.
Kerwin, Edward, Jacques Hébert, Nicola Gallagher, et al.. (2012). NVA237 Once Daily Provides Rapid And Sustained Bronchodilation In COPD Patients, With Efficacy Similar To Tiotropium: The GLOW2 Trial. A2920–A2920. 4 indexed citations
13.
D’Urzo, Anthony, Gary T. Ferguson, J.A. van Noord, et al.. (2011). Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial. Respiratory Research. 12(1). 156–156. 152 indexed citations
14.
Overend, Tim, Yimeng Lu, Michael Dolker, & Donald Banerji. (2010). Dose Response Of NVA237, A Long-acting Muscarinic Antagonist For The Treatment Of COPD. A4422–A4422. 2 indexed citations
15.
Tarpey, Thaddeus, Eva Petkova, Yimeng Lu, & Usha Govindarajulu. (2010). Optimal Partitioning for Linear Mixed Effects Models: Applications to Identifying Placebo Responders. Journal of the American Statistical Association. 105(491). 968–977. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaisheng Yin Breakdown of academic impact, for papers by Takatsugu Kojima Breakdown of academic impact, for papers by Arunava Ghosh Breakdown of academic impact, for papers by Martina Antošová Breakdown of academic impact, for papers by Petra Košútová Breakdown of academic impact, for papers by Misbahuddin M. Rafeeq Breakdown of academic impact, for papers by Zenglin Liao Breakdown of academic impact, for papers by Sanghun Lee Breakdown of academic impact, for papers by Nora Esteban-Cruciani Breakdown of academic impact, for papers by Martijn L. Manson
Rankless by CCL
2026